Australia Unveils Childhood Cancer Genomics Initiative

May 31, 2016

|

NEW YORK (GenomeWeb) – Australian Prime Minister Malcolm Turnbull today unveiled the Zero Childhood Cancer Initiative, a multi-year program that will leverage genomics to develop personalized therapeutic strategies for currently untreatable pediatric cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Featured White Papers

Bionano Genomics’ Next-Generation Mapping Identifies Large Structural Variants in Cancer and Genetic Disorders

Albumin & IgG Removal Reference Applications

Compatibility of POLYVIEW IHC Detection Reagents and HIGHDEF IHC Chromogens with Automated IHC Slide Stainers

Sep

27

Featured Webinar

Large-scale, Prospective Tumor and Normal Sequence to Accelerate Biomarker Discovery and Guide Clinical Care

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Oct

12

Featured Webinar

Precision Oncology Roundtable: Ask the Experts about NGS-based Tumor Profiling

This webinar will be a roundtable discussion on the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers.

Oct

17

Featured Webinar

Profiling the Tumor Immune Microenvironment During Neoadjuvant Therapy for Soft-Tissue Sarcomas

This webinar will discuss the benefits of genomically profiling the immune microenvironment of soft tissue sarcomas during neoadjuvant therapy.

Main menu